| Size | Price | Stock |
|---|---|---|
| 100 mg | Get quote | |
| 250 mg | Get quote | |
| 500 mg | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-121412 |
| M.Wt: | 459.53 |
| Formula: | C25H33NO7 |
| Purity: | >98 % |
| Solubility: | 10 mM in DMSO |
Lankacidin C is an inhibitor of protein synthesis in vitro. Lankacidin C inhibits the activity of L1210 leukemia, B16 melanoma and 6C3 HED/OG lymphosarcoma cell lines. Lankacidin C has antibacterial activity and antitumor activity[1][2].
In Vivo: Lankacidin C (75-1000 mg/kg; i.p.; once daily for 5 d) prolongs the mean survival time of (C57BL/6×DBA/2) F1 (BDF1) mice with dose-dependent manner. Lankacidin C (1000 mg/kg) significantly inhibits the growth of B-16 melanoma in C57BL/6 mice implanted B-16 melanoma[2].
Lankacidin C (300 mg/kg; i.p.; once daily for 6 d) inhibits the activity of L-1210 cells that resistance to 6-Mercaptopurine (HY-13677) or Cytosine Arabinoside (HY-13605) in BDF1 mice bearing L-1210/6-Mercaptopurine or L-1210/Cytosine Arabinoside[2].
Lankacidin C (10-100 mg/kg; i.p.; once daily for 5 d) significantly prolongs the mean survival time of C3H/He mice bearing 6C3HED/OG or 6C3HED/RG lymphosarcoma[2].
Lankacidin C (500 mg/kg; i.p.; once daily for 3 or 4 d) suppresses the production of antibody against sheep erythrocytes in ICR mice when administered before or after antigenic stimulation[2].
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information
Your information is safe with us.